The Specialist Premium
Specialization is emerging as one of the clearest sources of differentiated returns. According to McKinsey, specialist buyout funds outperformed generalist peers across 2010–2022 vintages, generating higher pooled IRRs (17% vs. 13%) and higher total value multiples (2.2x vs. 2.1x), with lower loss ratios (9% vs. 12%).
View chart in the full report
The outperformance is rooted in sector knowledge and operational skill, not just market timing. Specialists derived nearly 4x as much equity value from EBITDA growth as generalists (43% vs. 10%) and were far less dependent on multiple expansion (5% vs. 35% for generalists), a more resilient return profile that should hold up better as the industry's tailwinds fade further. For GPs willing to sharpen their sector focus, that's a durable edge rather than a cyclical one.
Size cuts in the same direction as sector focus. According to UBP, mid-market buyout funds have outperformed large-cap peers by an estimated 5–7% per year over the past decade, a gap it attributes to lower entry valuations, less competitive tension, and more room for operational improvement. SEB research showed that smaller buyouts offer lower entry valuation and a more natural path to the double-digit EBITDA growth today's return math requires.
We believe specialist firms outperform because of their in-depth knowledge of the sectors they operate in. At the same time, a highly concentrated portfolio also carries concentrated risks. Any unanticipated industry shift could affect multiple portfolio companies simultaneously, a risk to weigh when selecting sector-specific managers.
This content is for informational purposes only and does not constitute investment advice, an offer, or a solicitation to buy or sell any securities. Thirdpath, LLC is not acting as a fiduciary or financial advisor in providing this content. View our full disclosures.

